Safety and tolerability of efgartigimod in patients with generalized myasthenia gravis: Phase 3 adapt study results

被引：0
|
作者：
Mantegazza, Renato [1 ]
Bril, Vera [2 ]
Vu, Tuan [3 ]
Karam, Chafic [4 ]
Peric, Stojan [5 ]
Margania, Temur [6 ]
Murai, Hiroyuki [7 ]
Bilinska, Malgorzata [8 ]
Shakarishvili, Roman [9 ]
Smilowski, Marek [10 ]
Guglietta, Antonio [11 ]
Ulrichts, Peter [11 ]
Vangeneugden, Tony [11 ]
Utsugisawa, Kimiaki [12 ]
Verschuuren, Jan [13 ]
Howard, James [14 ]
机构：
[1] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Iv Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy
[2] Univ Toronto, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[3] Univ S Florida, Morsani Coll Med, Neurol, Tampa, FL 33620 USA
[4] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[5] Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia
[6] New Hosp, Dept Neurol & Neurorehabil, Tbilisi, Georgia
[7] Int Univ Hlth & Welf, Neurol, Tokyo, Japan
[8] Wroclaw Med Univ, Dept & Clin Neurol, Wroclaw, Poland
[9] Sarajishvili Inst Neurol & Neurosurg, Neurol, Tbilisi, Poland
[10] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland
[11] Argenx, Clin Dev, Ghent, Belgium
[12] Hanamaki Gen Hosp, Neurol, Hanamaki, Japan
[13] Leiden Univ, Med Ctr, Neurol, Leiden, Netherlands
[14] Univ N Carolina, Neurol, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷
关键词：
D O I：
10.1016/j.jns.2021.117764
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
117764
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Additional Analyses of the Phase 2 Efgartigimod Study in Myasthenia Gravis
    Howard, James
    Bril, Vera
    Mantegazza, Renato
    Beydoun, Said
    De Rivera Garrido, Fancisco Javier
    Piehl, Fredrik
    Rottoli, Maria Rosa
    Van Damme, Philip
    Vu, Tuan
    Ulrichts, Peter
    Guglietta, Antonio
    Beauchamp, Jon
    de Haard, Hans
    Verschuuren, Jan
    NEUROLOGY, 2020, 94 (15)
  • [42] The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis
    Tice, Jeffrey A.
    Touchette, Daniel R.
    Lien, Pei-Wen
    Agboola, Foluso
    Nikitin, Dmitriy
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (01): : 119 - 124
  • [43] A PHASE-3B OPEN-LABEL STUDY TO FURTHER INDIVIDUALIZE EFGARTIGIMOD TREATMENT OPTIONS FOR PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Gwathmey, Kelly
    Sahagian, Gregory
    Hussain, Yessar
    Feinberg, Marc
    Habib, Ali
    Skripuletz, Thomas
    Ruck, Tobias
    Brauer, Edward
    Gelinas, Deborah
    Zhao, Sihui
    Bogatyreva, Anna
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 66 : S141 - S142
  • [44] A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
    Pane, Chiara
    Di Stefano, Vincenzo
    Cuomo, Nunzia
    Sarnataro, Alessio
    Vinciguerra, Claudia
    Bevilacqua, Liliana
    Brighina, Filippo
    Rini, Nicasio
    Puorro, Giorgia
    Marsili, Angela
    Garibaldi, Matteo
    Fionda, Laura
    Sacca, Francesco
    JOURNAL OF NEUROLOGY, 2024, 271 (09) : 6209 - 6219
  • [45] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients
    Sacca, F.
    Cuomo, N.
    Russo, C.
    Campanile, M.
    Puorro, G.
    Marsili, A.
    Pane, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 569
  • [46] Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
    Sivadasan, Ajith
    Bril, Vera
    IMMUNOTHERAPY, 2023, 15 (08) : 553 - 563
  • [47] Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis
    Dewilde, Sarah
    Griffiths, Alison
    Qi, Cynthia Z.
    Phillips, Glenn
    Gelinas, Deborah
    Brauer, Edward
    Mantegazza, Renato
    Howard, James F.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 466
  • [48] MINIMAL SYMPTOM EXPRESSION IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS FROM TREATMENT WITH EFGARTIGIMOD
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Pasnoor, Mamatha
    Muppidi, Srikanth
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2021, 64 : S3 - S4
  • [49] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
    Barnett, Carolina
    Kaminski, Henry
    Benoit, Patrick
    Chen, Yixin
    Syed, Sana
    Turner, Timothy
    Smyth, Brendan
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S47 - S48
  • [50] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
    Barnett, Carolina
    Nicholson, Katharine
    Chen, Yixin
    Syed, Sana
    Turner, Timothy
    Smyth, Brendan
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S127 - S128
12345